Business

Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The Company is scheduled to present on Thursday, January 15, 2026, at 2:15 p.m. Ea

articleRapid Micro Biosystems, Inc.January 7, 20262/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-present-44th-140000491
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

About this update from Rapid Micro Biosystems, Inc.

[{"type":"image","alt":"Rapid Micro Biosystems, Inc.","displaySize":"","headline":null,"caption":"Rapid Micro Biosystems, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":155,"url":"https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t0NXhkXriNft2AMfxGKlHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0","width":300,"height":155}},"lazy":false},{"type":"text","content":"LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.","length":417,"tagName":"p"},{"type":"text","content":"The Company is scheduled to present on Thursday, January 15, 2026, at 2:15 p.m. Eastern Time (11:15 a.m. Pacific Time). A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event.","length":381,"tagName":"p"},{"type":"text","content":"About Rapid Micro Biosystems","length":28,"tagName":"p"},{"type":"text","content":"Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rel...

More updates from Rapid Micro Biosystems, Inc.

The Companyautomation solutionshealthcare productsmanufacturingMorgan Healthcare ConferenceCompany